An Observational Study on Postoperative Symptoms After Thyroidectomy (POS-T)
Launched by ILSAN CHA HOSPITAL · Nov 28, 2023
Trial Information
Current as of September 10, 2025
Recruiting
Keywords
ClinConnect Summary
**Clinical Trial Summary: Postoperative Symptoms After Thyroidectomy (POS-T)**
This clinical trial, called POS-T, is studying the experiences of patients who have had surgery to remove part or all of their thyroid gland due to thyroid cancer. The main goal is to understand how well patients handle their recovery after the surgery and to see how effective different management strategies are in reducing postoperative symptoms. The study is currently looking for participants who are 19 years or older, have been diagnosed with thyroid cancer, and have undergone surgery within the last month. Participants will also need to agree to receive treatment based on Chinese medicine.
If you or someone you know is considering joining this study, it’s important to know that all genders are welcome, and you will be asked to share your experiences post-surgery. However, this study cannot include individuals with certain serious health conditions or those who are pregnant or nursing. Participants will help researchers learn more about managing recovery after thyroid surgery, which could ultimately improve care for future patients. If you agree to take part, you’ll be contributing valuable information that can help others facing similar health challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 19 years of age or older
- • Those who have been confirmed to have a malignant tumor of the thyroid gland by biopsy or imaging
- • Subjects who have undergone partial thyroidectomy or total resection within 1 month
- • Those who have agreed to the implementation of Chinese medicine treatment
- • The Eastern Cooperative Oncology Group(ECOG) performance status 0-3
- • Those who understand the content of the study and agree to participate in the study
- Exclusion Criteria:
- • ○ When it is judged that other diseases other than cancer (dementia, cerebrovascular disease, severe organ failure, etc.) may have a significant effect on the decline of physical function
- • When it is judged that the life expectancy is less than 3 months and sufficient follow-up cannot be carried out
- • When emergency or major surgery or surgical intervention is required that takes precedence over postoperative treatment
- • Pregnant and lactating women
- • Other researchers who are judged to be unsuitable for research
About Ilsan Cha Hospital
Ilsan Cha Hospital is a leading healthcare institution dedicated to advancing medical research and patient care through innovative clinical trials. Located in South Korea, the hospital is part of the CHA Medical Group and is committed to enhancing health outcomes by conducting rigorous scientific studies across various medical fields. With a focus on patient safety and ethical standards, Ilsan Cha Hospital collaborates with experienced researchers and healthcare professionals to explore new treatment options and improve existing therapies. Their comprehensive approach integrates cutting-edge technology and a patient-centered philosophy, positioning them as a pivotal contributor to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gyeonggi Do, Korea, Republic Of
Gyeonggi Do, Korea, Republic Of
Seoul, Korea, Republic Of
Patients applied
Trial Officials
Jee Youg Lee
Principal Investigator
Ilsan Cha hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported